Please login to the form below
Zalviso
This page shows the latest Zalviso news and features for those working in and with pharma, biotech and healthcare.
Grunenthal and AcelRx’s Zalviso approved in EU
Zalviso is a non-invasive, handheld system that allows hospital patients to self-dose with sublingual sufenatil microtablets. ... delivery. AcelRx developed Zalviso and entered into a commercial collaboration with Grunenthal at the end of 2013.
Latest news
-
Shire and Baxalta drugs among CHMP's latest recommendations
Grunenthal's Zalviso (sufentanil) for the treatment of post-operative pain. A hybrid medicine, Zalviso's application relied in part on the results of studies carried out with a reference product
More from news
Approximately 2 fully matching, plus 0 partially matching documents found.
Latest Intelligence
-
Grünenthal's relentless pursuit of relief
It is our passion to help these patients.”. It is also investing in New Technical Entities (NTEs) which include new formulations and devices, acquiring Zalviso, a combination of a medical device
-
Pharma deals in September 2015
PDL BioPharma is buying out the majority of the expected royalty stream from EU sales of AcelRX's phase III product, Zalviso for $65m. ... Royalty monetisation. 110. AcelRx Pharmaceuticals. PDL BioPharma. Zalviso sub-lingual formulation of sufentanil.
More from intelligence
Approximately 0 fully matching, plus 2 partially matching documents found.
Featured jobs
- Scientific Director - Medical Education - Cheshire & London ...
-
Excellent Remuneration Package
- Senior Medical Writer– Medical Education – Oxford - London
-
Excellent Remuneration Package
- Scientific Director - Medical Communications Agency - New York
-
Excellent Remuneration Package
- Experienced / Senior Medical Writer - MedComms - Cardiff - Wales
-
Excellent Salary and Benefits on offer
-
Account Director, Medical Education
-
Salary TBC
- Account Manager / Senior Account Manager - Creative MedComms - C...
-
Excellent Remuneration
- Graduate / Entry Level Opportunities – Medical Communications – ...
-
Highly Competitive Remuneration Package
- Account Director, Healthcare Communications Agency
-
£54, 000- £60, 000
- Senior / Principal Medical Writer – Medical Education - UK &...
-
Excellent Salary and Benefits on offer
- Senior Medical Writer – Leading Medical Communications Agency – ...
-
Highly Competitive Remuneration Package
-
Senior Medical Writer
-
Salary TBC
Subscribe to our email news alerts
- Moving annual total (MAT)
- Genital herpes vaccine candidate heads for human studies
- Novartis highlights emerging assets and late-stage pipeline at R&D day
- Pfizer takeover rumour ignites Amarin shares
- Creativity in storytelling: why pharma must invest more in creativity
- PMEA - Pharmaceutical Market Excellence Awards
- Biogen defends aducanumab filing plan amid scepticism
- UCB’s bimekizumab beats AbbVie’s Humira in phase 3 trial
- Novartis strengthens case for its combination asthma drug
- OPEN Health Graduate Programme: from OPEN VIE to OPEN Health Medical Communications
- Sage slides off a MOUNTAIN as depression drug flunks trial
- Blind man's buff
PMHub
Red Health
Red Health was formed in 2007 to bring something fresh to the healthcare PR world. Our approach was simple –...
Latest intelligence
- OPEN Health Graduate Programme: from OPEN VIE to OPEN Health Medical Communications
- Isobel Owens shares her experience of the OPEN Health Graduate Programme from OPEN VIE to OPEN Health Medical Communications...
- Language barriers: Obesity has become a loaded word
- ...
- Spotlight interview: 15 minutes on digital in medical communications
- Gemma Allen, Head of Digital Communications, OPEN Health takes 15 minutes to answer some key questions on digital in medical communications...
Quick links
Infographics
